Literature DB >> 2788451

Tumour cell products inhibit both functional and immunoreactive interleukin 2 production by human blood lymphocytes.

M Nelson1, J A Bremner, D S Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2788451      PMCID： PMC2247037          DOI： 10.1038/bjc.1989.243

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  Contra-IL 2; a suppressor lymphokine that inhibits IL 2 activity.

Authors:  T Maki; S Satomi; M Gotoh; A P Monaco
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 3.  Cancer and subversion of host defences.

Authors:  D S Nelson; M Nelson; E Farram; Y Inoue
Journal:  Aust J Exp Biol Med Sci       Date:  1981-06

4.  Characterization of an inhibitor of cell division released in tumour cell cultures.

Authors:  J Werkmeister; J Zaunders; W McCarthy; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

5.  Inhibition of cytokine production by a tumor cell product.

Authors:  E Farram; M Nelson; D S Nelson; D K Moon
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

6.  Inhibition of interleukin 2 production by factors released from tumor cells.

Authors:  P Hersey; C Bindon; M Czerniecki; A Spurling; J Wass; W H McCarthy
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

7.  A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

Authors:  S A Rosenberg; M T Lotze; L M Muul; A E Chang; F P Avis; S Leitman; W M Linehan; C N Robertson; R E Lee; J T Rubin
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

8.  Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.

Authors:  H J Wanebo; R Pace; S Hargett; D Katz; J Sando
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

Review 9.  Natural killer cells: their roles in defenses against disease.

Authors:  R B Herberman; J R Ortaldo
Journal:  Science       Date:  1981-10-02       Impact factor: 47.728

10.  Inhibition of cell-mediated immunity by tumour cell products: depression of interleukin-2 production and responses to interleukin-2 by mouse spleen cells.

Authors:  M Nelson; D S Nelson
Journal:  Immunol Cell Biol       Date:  1988-04       Impact factor: 5.126
View more
  1 in total

1.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.